Nonpartisan civic infrastructure
AllCiv·Legis1
·

H.R. 2301

BillFederalHouseIn Committee
Clinical Trial Cancer Mission 2020 Act
About This Bill
Committee
Latest Action · June 7, 2013
Referred to the Subcommittee on Health.
Congress
113th (2013–2015)
Introduced
June 6, 2013
Cosponsors (2)
1D 1R
View PDF ↗

Summary

Highlight any text to annotate
Clinical Trial Cancer Mission 2020 Act - Revises clinical trial registry data bank provisions of the Public Health Service Act to: (1) include a device or drug clinical trial whether or not it results in a positive or negative outcome, and (2) subject clinical trials funded by the Department of Defense (DOD) to requirements to certify information submissions to the Director of the National Institutes of Health (NIH). Restricts funding for a grantee and makes the grantee liable to the United States for repayment of any grant amount provided, if the grantee has not submitted clinical trial information within the 30-day correction period for noncompliance.

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.